Helicobacter pylori-induced inhibition of vascular endothelial cell functions: A role for VacA-dependent nitric oxide reduction

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 295, Issue 4, 2008, Pages

  Tobin, Nicholas P ^a   Henehan, Gary T ^b   Murphy, Ronan P ^a   Atherton, John C ^c   Guinan, Anthony F ^a   Kerrigan, Steven W ^d   Cox, Dermot ^d   Cahill, Paul A ^a   Cummins, Philip M ^a  

^a DUBLIN CITY UNIVERSITY   (Ireland)

^b DUBLIN INSTITUTE OF TECHNOLOGY   (Ireland)

^c NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^d ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

Shear stress; Vacuolating cytotoxin A

Indexed keywords

5 NITRO 2 (3 PHENYLPROPYLAMINO)BENZOIC ACID; DEXTRAN 40; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; VACUOLATING TOXIN;

AORTA; ARTICLE; CELL FUNCTION; CELL MEMBRANE PERMEABILITY; CELL MIGRATION; CELL PROLIFERATION; CHEMICAL ANALYSIS; CONTROLLED STUDY; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; ESCHERICHIA COLI; HELICOBACTER PYLORI; IMMUNOLOCALIZATION; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; SHEAR STRESS; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

ANIMALS; BACTERIAL PROTEINS; CATTLE; CELL MEMBRANE PERMEABILITY; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; DOWN-REGULATION; ENDOTHELIAL CELLS; ENZYME INHIBITORS; HELICOBACTER PYLORI; MEMBRANE PROTEINS; NEOVASCULARIZATION, PHYSIOLOGIC; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE; NITROBENZOATES; PHOSPHOPROTEINS; S-NITROSO-N-ACETYLPENICILLAMINE; STRESS, MECHANICAL;

EID: 57049112792     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00240.2008     Document Type: Article

References (69)

1. Ameriso SF, Esteban A, Fridman MD, Leiguarda RC, Gustavo E, Sevlever MD. Detection of Helicobacter pylori in human carotid atherosclerotic plaques. Stroke 32: 385-391, 2001.
2. Ameriso SF, Villamil AR, Zedda C, Parodi JC, Garrido S, Sarchi MI, Schultz M, Boczkowski J, Sevlever GE. Heme oxygenase-1 is expressed in carotid atherosclerotic plaques infected with Helicobacter pylori and is more prevalent in asymptomatic subjects. Stroke 36: 1896-1900, 2005.
3. Ando T, Minami M, Ishiguro K, Maeda O, Watanabe O, Mizuno T, Fujita T, Takahashi H, Noshiro M, Goto H. Changes in biochemical parameters related to atherosclerosis after Helicobacter pylori eradication. Aliment Pharmacol Ther 24, Suppl 4: 58-64, 2006.
4. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dyebinding. Anal Biochem 72: 248-254, 1976.
5. Brisslert M, Enarsson K, Lundin S, Karlsson A, Kusters JG, Svennerholm AM, Backert S, Quiding-Jarbrink M. Helicobacter pylori induce neutrophil transendothelial migration: role of the bacterial HP-NAP. FEMS Microbiol Lett 249: 95-103, 2005.
6. Coen P, Cummins P, Birney Y, Devery R, Cahill P. Modulation of PGF-1́ and nitric oxide production in bovine aortic endothelial cells by conjugated linoleic acid. Endothelium 11: 211-220, 2004.
7. Colgan OC, Ferguson G, Collins NT, Murphy RP, Meade G, Cahill PA, Cummins PM. Regulation of brain microvascular endothelial tight junction assembly and barrier function by steady and pulsatile shear stress. Am J Physiol Heart Circ Physiol 292: H3190-H3197, 2007.
8. Collins NT, Cummins PM, Colgan OC, Ferguson G, Birney YA, Murphy RP, Meade G, Cahill PA. Cyclic strain-mediated regulation of vascular endothelial occludin and ZO-1: influence on intercellular tight junction assembly and function. Arterioscler Thromb Vasc Biol 26: 62-68, 2006.
9. Corrado E, Novo S. Role of inflammation and infection in vascular disease. Acta Chir Belg 105: 567-579, 2005.
10. Cover TL, Blanke SR. Helicobacter pylori VacA, a paradigm for toxin multifunctionality. Nat Rev Microbiol 3: 320-332, 2005.
11. Cover TL, Krishna US, Israel DA, Peek RM Jr. Induction of gastric epithelial cell apoptosis by Helicobacter pylori vacuolating cytotoxin. Cancer Res 63: 951-957, 2003.
12. Davi G, Neri M, Falco A, Festi D, Taraborelli T, Ciabattoni G, Basili S, Cuccurullo F, Patrono C. Helicobacter pylori infection causes persistent platelet activation in vivo through enhanced lipid peroxidation. Arterioscler Thromb Vasc Biol 25: 246-251, 2005.
13. de Jonge HW, Dekkers DH, Tilly BC, Lamers JM. Cyclic stretch and endothelin-1 mediated activation of chloride channels in cultured neonatal rat ventricular myocytes. Clin Sci (Lond) 103, Suppl 48: 148S-151S, 2003.
14. Elkind MS, Cole JW. Do common infections cause stroke? Semin Neurol 26: 88-99, 2006.
15. Enarsson K, Brisslert M, Backert S, Quiding-Jarbrink M. Helicobacter pylori induces transendothelial migration of activated memory T cells. Infect Immun 73: 761-769, 2005.
16. Espinola-Klein C, Rupprecht HJ, Blankenberg S, Bickel C, Kopp H, Rippin G, Victor A, Hafner G, Schlumberger W, Meyer J. Impact of infectious burden on extent and long term prognosis of atherosclerosis. Circulation 105: 15-21, 2002.
17. Farsak B, Yildirir A, Akyon Y, Pinar A, Oc M, Boke E, Kes S, Tokgozoglu L. Detection of Chlamydia pneumoniae and Helicobacter pylori DNA in human atherosclerotic plaques by PCR. J Clin Microbiol 38: 4408-4411, 2000.
18. Figueiredo C, Machado JC, Yamaoka Y. Pathogenesis of Helicobacter pylori infection. Helicobacter 10: 14-20, 2005.
19. Gobert AP, McGee DJ, Akhtar M, Mendz GL, Newton JC, Cheng Y, Mobley HL, Wilson KT. Helicobacter pylori arginase inhibits nitric oxide production by eukaryotic cells: a strategy for bacterial survival. Proc Natl Acad Sci USA 98: 13844-13849, 2001.
20. Grabczewska Z, Nartowicz E, Kubica J, Rosc D. Endothelial function parameters in patients with unstable angina and infection with Helicobacter pylori and Chlamydia pneumoniae. Eur J Intern Med 17: 339-342, 2006.
21. Guo FH, Yan XM, Fan CX, Zhao F, Xiao D, Zeng X, Zhang MJ, He LH, Meng FL, Zhang JZ. Cross-reactivity of anti-H. pylori antibodies with membrane antigens of human erythrocytes. World J Gastroenterol 13: 3742-3746, 2007.
22. Hagiwara N, Toyoda K, Inoue T, Shimada H, Ibayashi S, Iida M, Okada Y. Lack of association between infectious burden and carotid atherosclerosis in Japanese patients. J Stroke Cerebrovasc Dis 16: 145-152, 2007.
23. Handa O, Naito Y, Yoshikawa T. CagA protein of Helicobacter pylori: a hijacker of gastric epithelial cell signaling. Biochem Pharmacol 73: 1687-1702, 2007.
24. Hisatsune J, Nakayama M, Isomoto H, Kurazono H, Mukaida N, Mukhopadhyay AK, Azuma T, Yamaoka Y, Sap J, Yamasaki E, Yahiro K, Moss J, Hirayama T. Molecular characterization of Helicobacter pylori VacA induction of IL-8 in U937 cells reveals a prominent role for p38MAPK in activating transcription factor-2, cAMP response element binding protein, and NF-kappaB activation. J Immunol 180: 5017-5027, 2008.
25. Hoffmeister A, Rothenbacher D, Bode G, Persson K, Marz W, Nauck MA, Brenner H, Hombach V, Koenig W. Current infection with Helicobacter pylori, but not seropositivity to Chlamydia pneumoniae or cytomegalovirus, is associated with an atherogenic, modified lipid profile. Arterioscler Thromb Vasc Biol 21: 427-432, 2001.
26. Innocenti M, Thoreson AC, Ferrero RL, Stromberg E, Bolin I, Eriksson L, Svennerholm AM, Quiding-Jarbrink M. Helicobacter pylori-induced activation of human endothelial cells. Infect Immun 70: 4581-4590, 2002.
27. Jacobson JR, Dudek SM, Singleton PA, Kolosova IA, Verin AD, Garcia JG. Endothelial cell barrier enhancement by ATP is mediated by the small GTPase Rac and cortactin. Am J Physiol Lung Cell Mol Physiol 291: L289-L295, 2006.
28. Jenkinson L, Bardhan KD, Atherton J, Kalia N. Helicobacter pylori prevents proliferative stage of angiogenesis in vitro: role of cytokines. Dig Dis Sci 47: 1857-1862, 2002.
29. Kalia N, Jones C, Bardhan DK, Reed MW, Atherton JC, Brown NJ. Effects of genotypically different strains of Helicobacter pylori on human microvascular endothelial cells in vitro. Dig Dis Sci 46: 54-61, 2001.
30. Kamiya S. Analysis of virulence factors of Helicobacter pylori. Rinsho Byori 49: 116-120, 2001.
31. Kanbay M, Gur G, Yucel M, Yilmaz U, Boyacioglu S. Does eradication of Helicobacter pylori infection help normalize serum lipid and CRP levels? Dig Dis Sci 50: 1228-1231, 2005.
32. Ki MR, Lee HR, Goo MJ, Hong IH, Do SH, Jeong DH, Yang HJ, Yuan DW, Park JK, Jeong KS. Differential regulation of ERK1/2 and p38 MAP kinases in VacA-induced apoptosis of gastric epithelial cells. Am J Physiol Gastrointest Liver Physiol 294: G635-G647, 2008.
33. Konturek PC, Konturek SJ, Pierzchalski P, Bielanski W, Duda A, Marlicz K, Starzynska T, Hahn FG. Cancerogenesis in Helicobacter pylori infected stomach: role of growth factors, apoptosis and cyclooxygenases. Med Sci Monit 7: 1092-1107, 2001.
34. Kou R, Michel T. Epinephrine regulation of the endothelial nitric oxide synthase: roles of Rac1 and beta3-adrenergic receptors in endothelial NO signaling. J Biol Chem 282: 32719-32729, 2007.
35. Kowalski M, Pawlik M, Konturek JW, Konturek SJ. Helicobacter pylori infection in coronary artery disease. J Physiol Pharmacol 57, Suppl 3: 101-111, 2006.
36. Kowalski M, Rees W, Konturek PC, Grove R, Scheffold T, Meixner H, Brunec M, Franz N, Konturek JW, Pieniazek P, Hahn EG, Konturek SJ, Thale J, Warnecke H. Detection of Helicobacter pylori specific DNA in human atheromatous coronary arteries and its association to prior myocardial infarction and unstable angina. Dig Liver Dis 34: 398-402, 2002.
37. Kurosawa A, Miwa H, Hirose M, Tsune I, Nagahara A, Sato N. Inhibition of cell proliferation and induction of apoptosis by Helicobacter pylori through increased phosphorylated p53, p21 and Bax expression in endothelial cells. J Med Microbiol 51: 385-391, 2002.
38. Laemmli U. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
39. Laurila A, Bloigu A, Nayha S, Hassi J, Leinonen M, Saikku P. Association of Helicobacter pylori infection with elevated serum lipids. Atherosclerosis 142: 207-210, 1999.
40. Levine YC, Li GK, Michel T. Agonist-modulated regulation of AMP-activated protein kinase (AMPK) in endothelial cells: evidence for an AMPK-Rac1-Akt-endothelial nitric oxide synthase pathway. J Biol Chem 282: 20351-20364, 2007.
41. Liuba P, Pesonen E, Paakkari I, Batra S, Anderson L, Forslid A, Yla-Herttuala S, Persson K, Wadstrom T, Wang X, Laurini R. Co-infection with Chlamydia pneumoniae and Helicobacter pylori results in vascular endothelial dysfunction and enhanced VCAM-1 expression in apoE-knockout mice. J Vasc Res 40: 115-122, 2003.
42. Mach F, Sukhova GK, Michetti M, Libby P, Michetti P. Influence of Helicobacter pylori infection during atherogenesis in vivo in mice. Circ Res 90: E1-E4, 2002.
43. Manolakis A, Kapsoritakis AN, Potamianos SP. A review of the postulated mechanisms concerning the association of Helicobacter pylori with ischemic heart disease. Helicobacter 12: 287-297, 2007.
44. Manolopoulos VG, Liekens S, Koolwijk P, Voets T, Peters E, Droogmans G, Lelkes P, de Clercq E, Nilius B. Inhibition of angiogenesis by blockers of volume-regulated anion channels. Gen Pharmacol 34: 107-116, 2000.
45. Marra M, Bonfigli AR, Bonazzi P, Galeazzi R, Sirolla C, Testa I, Cenerelli S, Boemi M, Testa R. Asymptomatic Helicobacter pylori infection increases asymmetric dimethylarginine levels in healthy subjects. Helicobacter 10: 609-614, 2005.
46. Matsushita K, Morrell CN, Cambien B, Yang SX, Yamakuchi M, Bao C, Hara MR, Quick RA, Cao RW, O'Rourke B, Lowenstein JM, Pevsner J, Wagner DD, Lowenstein CJ. Nitric oxide regulates exocytosis by S-nitrosylation of N-ethylmaleimide-sensitive factor. Cell 115: 127-129, 2003.
47. Nabwera HM, Logan RP. Epidemiology of Helicobacter pylori: transmission, translocation and extragastric reservoirs. J Physiol Pharmacol 50: 711-722, 1999.
48. Olivera-Severa D, Wassermann GE, Carlini CR. Ureases display biological effects independent of enzymatic activity: is there a connection to diseases caused by urease-producing bacteria? Braz J Med Biol Res 39: 851-861, 2006.
49. Oshima T, Ozono R, Yano Y, Oishi Y, Teragawa H, Higashi Y, Yoshizumi M, Kambe M. Association of Helicobacter pylori infection with systemic inflammation and endothelial dysfunction in healthy male subjects. J Am Coll Cardiol 45: 1219-1222, 2005.
50. Pai R, Sasaki E, Tarnawski AS. Helicobacter pylori vacuolating cytotoxin (VacA) alters cytoskeleton-associated proteins and interferes with re-epithelialization of wounded gastric epithelial monolayers. Cell Biol Int 24: 291-301, 2000.
51. Panchal PC, Forman JS, Blumberg DR, Wilson KT. Helicobacter pylori infection: pathogenesis. Curr Opin Gastroenterol 19: 4-10, 2003.
52. Pearce HR, Kalia N, Bardhan KD, Atherton JC, Brown NJ. Effects of Helicobacter pylori on endothelial cell proliferation and chemotaxis. Digestion 69: 201-210, 2004.
53. Pelicic V, Reyrat JM, Sartori L, Pagliaccia C, Rappuoli R, Telford JL, Montecucco C, Papini E. Helicobacter pylori VacA cytotoxin associated with the bacteria increases epithelial permeability independently of its vacuolating activity. Microbiology 145: 2043-2050, 1999.
54. Polenghi A, Bossi F, Fischetti F, Durigutto P, Cabrelle A, Tamassia N, Cassatella MA, Montecucco C, Tedesco F, de Bernard M. The neutrophil activating protein of Helicobacter pylori crosses endothelia to promote neutrophil adhesion in vivo. J Immunol 178: 1312-1320, 2007.
55. Prasad A, Zhu J, Halcox JPJ, Waclawiw MA, Epstein SE, Quyyumi AA. Predisposition to atherosclerosis by infections: role of endothelial dysfunction. Circulation 106: 184-190, 2002.
56. Qamirani E, Ren Y, Kuo L, Hein TW. C-reactive protein inhibits endothelium-dependent NO-mediated dilation in coronary arterioles by activating p38 kinase and NAD(P)H oxidase. Arterioscler Thromb Vasc Biol 25: 995-1001, 2005.
57. Reyrat JM, Pelicic V, Papini E, Montecucco C, Rappuoli R, Telford JL. Towards deciphering the Helicobacter pylori cytotoxin. Mol Microbiol 34: 197-204, 1999.
58. Rouzaire-Dubois B, Dubois JM. K+ channel block-induced mammalian neuroblastoma cell swelling: a possible mechanism to influence proliferation. J Physiol 510: 93-102, 1998.
59. Russo G, Leopold JA, Loscalzo J. Vasoactive substances: nitric oxide and endothelial dysfunction in atherosclerosis. Vascul Pharmacol 38: 259-269, 2002.
60. Simionescu M. Implications of early structural-functional changes in the endothelium for vascular disease. Arterioscler Thromb Vasc Biol 27: 266-274, 2007.
61. Sun J, Aoki K, Zheng JX, Su BZ, Ouyang XH, Misumi J. Effect of NaCl and Helicobacter pylori vacuolating cytotoxin on cytokine expression and viability. World J Gastroenterol 12: 2174-2180, 2006.
62. Sundrud MS, Torres VJ, Unutmaz D, Cover TL. Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin (VacA) is independent of VacA effects on IL-2 secretion. Proc Natl Acad Sci USA 101: 7727-7732, 2004.
63. Szabo I, Brutsche S, Tombola F, Moschioni M, Satin B, Telford JL, Rappuoli R, Montecucco C, Papini E, Zoratti M. Formation of anion-selective channels in the cell plasma membrane by the toxin VacA of Helicobacter pylori is required for its biological activity. EMBO J 18: 5517-5527, 1999.
64. Tojo A, Onozato ML, Kobayashi N, Goto A, Matsuoka H, Fujita T. Antioxidative effect of p38 mitogen-activated protein kinase inhibitor in the kidney of hypertensive rat. J Hypertens 23: 165-174, 2005.
65. Traub O, Berk BC. Laminar shear stress: mechanisms by which endothelial cells transduce an atheroprotective force. Arterioscler Thromb Vasc Biol 18: 677-685, 1998.
66. von Offenberg Sweeney N, Cummins PM, Cotter EJ, Fitzpatrick PA, Birney YA, Redmond EM, Cahill PA. Cyclic strain-mediated regulation of vascular endothelial cell migration and tube formation. Biochem Biophys Res Commun 329: 573-582, 2005.
67. Wada A, Yamasaki E, Hirayama T. Helicobacter pylori vacuolating cytotoxin, VacA, is responsible for gastric ulceration. Biochem J 136: 741-746, 2004.
68. Weiss TW, Kvakan H, Kaun C, Prager M, Speidl WS, Zorn G, Pfaffenberger S, Huk I, Maurer G, Huber K, Wojta J. No evidence for a direct role of Helicobacter pylori and Mycoplasma pneumoniae in carotid artery atherosclerosis. J Clin Pathol 59: 1186-1190, 2006.
69. Willhite DC, Cover TL, Blanke SR. Cellular vacuolation and mitochondrial cytochrome C release are independent outcomes of Helicobacter pylori vacuolating cytotoxin activity that are each dependent on membrane channel formation. J Biol Chem 278: 48204-48209, 2003.